Acorn Creek Capital’s Eli Lilly LLY Stock Holding History

Acorn Creek Capital’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.27M	Sell	1,059 -53	-5%	-$54.2K	0.42%	23
2026 Q1	$1.02M	Sell	1,112 -42	-4%	-$42.6K	0.37%	22
2025 Q4	$1.24M	Buy	1,154 +295	+34%	+$282K	0.45%	20
2025 Q3	$656K	Buy	859 +10	+1%	+$7.44K	0.25%	28
2025 Q2	$662K	Sell	849 -43	-5%	-$33.4K	0.27%	26
2025 Q1	$737K	Sell	892 -29	-3%	-$24.1K	0.37%	25
2024 Q4	$711K	Sell	921 -12	-1%	-$9.94K	0.37%	29
2024 Q3	$827K	Buy	933 +6	+0.6%	+$5.39K	0.44%	24
2024 Q2	$840K	Buy	927 +12	+1%	+$9.6K	0.5%	24
2024 Q1	$712K	Buy	915 +3	+0.3%	+$2.13K	0.45%	27
2023 Q4	$532K	Buy	+912	New	+$532K	0.24%	36

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Acorn Creek Capital's LLY Position: Q2 2026 in Review

Acorn Creek Capital reduced its Eli Lilly (LLY) stake by 4.8% in Q2 2026, selling an estimated $54.2K and leaving 1,059 shares worth $1.27M. The position accounts for 0.42% of the portfolio, ranked #23.

Acorn Creek Capital first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Acorn Creek Capital held 1,059 shares of Eli Lilly worth $1.27M as of Q2 2026.
Acorn Creek Capital sold 53 Eli Lilly shares in Q2 2026, an estimated $54.2K.
Eli Lilly made up 0.42% of Acorn Creek Capital's portfolio in Q2 2026, its #23 holding.
Acorn Creek Capital first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Acorn Creek Capital's 13F filing for Q2 2026, filed 6 Aug 2026.